Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cel-Sci Corp (AMEX:CVM) (was HIV) -- Ignore unavailable to you. Want to Upgrade?

To: Tom Shutters who wrote (2767)	1/23/2000 12:43:00 PM
From: Toni Wheeler	Read Replies (1) \| Respond to of 2836

Tom, The activity in the price and volume for HIV on Friday may very well be the renewed push from our politicians and 'raising all boats' in the bio sector.... however, this is an interestin' report from a Yahoo! investor/poster....coincidence or ??....: <<<Talked to Investor Relations by: pharmascoop 1/22/00 5:27 pm Msg: 13180 of 13199 For those long on the stock...I spoke to Darryl in Investor Relations late last week. Of course she had nothing specific to say because she could not give that information even if she had it but several hints were excellent news to me...Look for article in major scientific journal on one of the concluded studies anytime now...Paper is in its last review stage by the editors now...The key things in the data will be tumor reduction rates and FOLLOW-UP PROGRESS REPORTS...i.e.THESE PEOPLE ARE STILL ALIVE...Great quality of life issues with this MULTIKINE drug...Once we break thru $4 range there will be little resistance...Finially, after article and price above $5, we can get BIG BLOCKS from institutional investors whom are currently limited to investing in stocks under $5. Good luck to all longs and thanks to fmrick, sol, and other regulars on this site who keep us others up to date.>>>